CVS Health Corp (NYSE:CVS)
| 89.97 Delayed Data As of Dec 02 |  +1.19 / +1.34%Today’s Change | 67.06 Today|||52-Week Range 96.57 | +31.73% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Merlo Larry J Director |  Sale | 3/26/2021 | 270,650 | $74.73 | $20.2M | +18.47% |
Merlo Larry J Director |  Buy | 3/26/2021 | 271,347 | $74.29 | $20.2M | +18.47% |
Roberts Jonathan C Chief Operating Officer & Executive Vice President | Sale | 11/03/2021 | 108,870 | $95.00 | $10.3M | -6.59% |
Moriarty Thomas M /medco/ General Counsel & Executive Vice President | Sale | 5/10/2021 | 109,469 | $86.00 | $9.4M | +4.82% |
Moriarty Thomas M /medco/ General Counsel & Executive Vice President | Sale | 4/21/2021 | 101,003 | $77.00 | $7.8M | +17.33% |
Brennan Troyen A Chief Medical Officer & Executive Vice President | Sale | 10/26/2021 | 80,802 | $88.00 | $7.1M | +1.89% |
Moriarty Thomas M /medco/ General Counsel & Executive Vice President | Buy | 5/10/2021 | 109,469 | $62.21 | $6.8M | +4.82% |
Merlo Larry J Director | Sale | 4/01/2021 | 81,700 | $74.30 | $6.1M | +21.12% |
Roberts Jonathan C Chief Operating Officer & Executive Vice President | Sale | 4/01/2021 | 79,714 | $74.30 | $5.9M | +21.12% |
Brennan Troyen A Chief Medical Officer & Executive Vice President | Sale | 6/15/2021 | 67,552 | $86.00 | $5.8M | +5.37% |
Page of 10